Connect
MJA
MJA

Screening for post‐stroke depression: who, when and how?

Katherine Sewell, Tamara Tse, Geoffrey A Donnan and Leeanne M Carey
Med J Aust 2021; 215 (7): . || doi: 10.5694/mja2.51256
Published online: 4 October 2021

What Australia can learn from overseas guidelines

Depression is a common sequela of stroke, with about 30% of stroke survivors developing depression.1 The Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM‐5) recognises post‐stroke depression within the category “Depressive disorder due to another medical condition”.2 Post‐stroke depression significantly hinders patients’ ability to participate in rehabilitation and is associated with poor health outcomes. Despite its high prevalence and negative impact, post‐stroke depression is vastly underdiagnosed.3 One estimate suggested that only 5% of stroke survivors are diagnosed with and treated for depression in routine clinical practice.4 Diagnosis of depression can be challenging in stroke survivors, especially in those who have residual communication and cognitive impairments.


  • 1 La Trobe University, Melbourne, VIC
  • 2 Florey Institute of Neuroscience and Mental Health, Melbourne, VIC
  • 3 St Vincent's Hospital, Melbourne, VIC
  • 4 Melbourne Brain Centre at The Royal Melbourne Hospital, Melbourne, VIC



Acknowledgements: 

Katherine Sewell is the recipient of a La Trobe University postgraduate scholarship for undertaking a PhD, which supported her during the writing of this article.

Competing interests:

No relevant disclosures.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.